Parkinson's Disease Research Today is a free monthly online journal that collates and summarizes the latest research about Parkinson's Disease, including details on symptoms, treatment, genetics, medication.

Volume 2 (2005), Issue 7 (July)

1. A proteomic approach in the study of an animal model of Parkinson's disease.
   Clin Chim Acta, 357(2): 202-9. [Abstract] [Full-text]
2. Utility of electrogastrography in differentiating Parkinson's disease with or without gastrointestinal symptoms: a prospective controlled study.
   Digestion, 71(3): 187-91. [Abstract] [Full-text]
3. Sleep disturbances in Japanese patients with Parkinson's disease--comparing with patients in the UK.
   J Neurol Sci, 234(1): 73-8. [Abstract] [Full-text]
4. Apolipoprotein E4 is probably responsible for the chromosome 19 linkage peak for Parkinson's disease.
   Am J Med Genet B Neuropsychiatr Genet, 136(1): 72-4. [Abstract] [Full-text]
5. Psychotic symptoms in Parkinson's disease. From description to etiology.
   J Neurol, 252(7): 753-64. [Abstract] [Full-text]
6. Glutathione depletion in a midbrain-derived immortalized dopaminergic cell line results in limited tyrosine nitration of mitochondrial complex I subunits: implications for Parkinson's disease.
   Antioxid Redox Signal, 7(7): 900-10. [Abstract] [Full-text]
7. Interaction of DJ-1 with Daxx inhibits apoptosis signal-regulating kinase 1 activity and cell death.
   Proc Natl Acad Sci U S A, 102(27): 9691-6. [Abstract] [Full-text]
8. The BDNF Val66Met polymorphism has a gender specific influence on planning ability in Parkinson's disease.
   J Neurol, 252(7): 833-8. [Abstract] [Full-text]
9. Identification of risk and age-at-onset genes on chromosome 1p in Parkinson disease.
   Am J Hum Genet, 77(2): 252-64. [Abstract] [Full-text]
10. A pilot study of therapeutic massage for people with Parkinson's disease: the added value of user involvement.
    Complement Ther Clin Pract, 11(3): 161-71. [Abstract] [Full-text]
11. Cost-effectiveness of levodopa/carbidopa/entacapone (Stalevo) compared to standard care in UK Parkinson's disease patients with wearing-off.
    Curr Med Res Opin, 21(7): 1005-14. [Abstract] [Full-text]
12. Prevalence and incidence of Parkinson's disease in Europe.
    Eur Neuropsychopharmacol, 15(4): 473-90. [Abstract] [Full-text]
13. Function of sigma1 receptors in Parkinson's disease.
    Acta Neurol Scand, 112(2): 103-7. [Abstract] [Full-text]
14. Bromocriptine treatment in a murine Parkinson's model: ultrastructural evaluation after dopaminergic deafferentation.
    Int J Neurosci, 115(6): 851-9. [Abstract] [Full-text]
15. Long-term therapeutic effects on parkinsonian rats of intrastriatal co-grafts with genetically engineered fibroblasts expressing tyrosine hydroxylase and glial cell line-derived neurotrophic factor.
    Int J Neurosci, 115(6): 769-79. [Abstract] [Full-text]
16. The first evaluation of brain shift during functional neurosurgery by deformation field analysis.
    J Neurol Neurosurg Psychiatry, 76(8): 1161-3. [Abstract] [Full-text]
17. Neurodegenerative disorders: Parkinson's disease and Huntington's disease.
    J Neurol Neurosurg Psychiatry, 76(8): 1058-63. [Abstract] [Full-text]
18. Brain 3D-SSP SPECT analysis in dementia with Lewy bodies, Parkinson's disease with and without dementia, and Alzheimer's disease.
    Clin Neurol Neurosurg, 107(5): 396-403. [Abstract] [Full-text]
19. Oscillatory pallidal local field potential activity inversely correlates with limb dyskinesias in Parkinson's disease.
    Exp Neurol, 194(2): 523-9. [Abstract] [Full-text]
20. AAV2-mediated gene delivery to monkey putamen: evaluation of an infusion device and delivery parameters.
    Exp Neurol, 194(2): 476-83. [Abstract] [Full-text]
21. Movement precues in planning and execution of aiming movements in Parkinson's disease.
    Exp Neurol, 194(2): 393-409. [Abstract] [Full-text]
22. Molecular pathophysiology of Parkinson's disease.
    Annu Rev Neurosci, 28: 57-87. [Abstract] [Full-text]
23. Reciprocal interactions between oscillatory activities of different frequencies in the subthalamic region of patients with Parkinson's disease.
    Eur J Neurosci, 22(1): 257-66. [Abstract] [Full-text]
24. Altered alpha-synuclein homeostasis causing Parkinson's disease: the potential roles of dardarin.
    Trends Neurosci, 28(8): 416-21. [Abstract] [Full-text]

© 2004-2008 Parkinson's Disease Research Today. All Rights Reserved.